|
gene silencing by mirna
|
GO:0035195 |
10 |
0.577
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.506
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.419
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.310
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.232
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.229
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.210
|
|
|
histone modification
|
GO:0016570 |
159 |
0.125
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.112
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.108
|
|
|
methylation
|
GO:0032259 |
134 |
0.097
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.093
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.089
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.075
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.073
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.072
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.070
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.070
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.069
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.063
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.061
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.058
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.057
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.056
|
|
|
rna processing
|
GO:0006396 |
105 |
0.055
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.055
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.055
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.055
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.053
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.053
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.052
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.052
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.052
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.052
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.051
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.051
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.050
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.049
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.049
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.049
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.048
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.046
|
|
|
regionalization
|
GO:0003002 |
337 |
0.044
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.044
|
|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.044
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.044
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.042
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.042
|
|
|
renal system development
|
GO:0072001 |
225 |
0.040
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.040
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.040
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.039
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.039
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.037
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.036
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.036
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.036
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.036
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.036
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.036
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.035
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.035
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.035
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.035
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.035
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.034
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.033
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.033
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.033
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.033
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.032
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.032
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.031
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.031
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.031
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.031
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.030
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.030
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.030
|
|
|
ossification
|
GO:0001503 |
216 |
0.030
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.030
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.029
|
|
|
dna modification
|
GO:0006304 |
50 |
0.029
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.028
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.027
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.027
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.027
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.027
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.026
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.026
|
|
|
kidney development
|
GO:0001822 |
213 |
0.026
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.026
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.025
|
|
|
positive regulation of t cell anergy
|
GO:0002669 |
4 |
0.025
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.025
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.024
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.024
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.024
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.023
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.022
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.022
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.022
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.022
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.022
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.022
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.022
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.021
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.021
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.021
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.021
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.021
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.020
|
|
|
regulation of lymphocyte anergy
|
GO:0002911 |
4 |
0.020
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.020
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.020
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.020
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.020
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.020
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.020
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.020
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.020
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.019
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.019
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.019
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.019
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.019
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.019
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.019
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.019
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.019
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.019
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.018
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.018
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.018
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.018
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.018
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.018
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.018
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.018
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.018
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.017
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.017
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.017
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.017
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.017
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.017
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.017
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.017
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.017
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.017
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.017
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.017
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.017
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.017
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.017
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.016
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.016
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.016
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.016
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.016
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.016
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.016
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.016
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.016
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.016
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.016
|
|
|
habenula development
|
GO:0021986 |
2 |
0.016
|
|
|
gonad development
|
GO:0008406 |
141 |
0.016
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.016
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.016
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.016
|
|
|
placenta development
|
GO:0001890 |
140 |
0.016
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.016
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.016
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.016
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.016
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.016
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.015
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.015
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.015
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.015
|
|
|
gland development
|
GO:0048732 |
330 |
0.015
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.015
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.015
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.015
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.015
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.015
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.015
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.015
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.015
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.014
|
|
|
tube formation
|
GO:0035148 |
140 |
0.014
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.014
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.014
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.014
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.014
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.014
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.014
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.014
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.014
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.014
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.014
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.014
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.014
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.014
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.014
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.014
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.014
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.014
|
|
|
regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060211 |
4 |
0.014
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.014
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.013
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.013
|
|
|
appendage development
|
GO:0048736 |
166 |
0.013
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.013
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.013
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.013
|
|
|
regulation of protein sumoylation
|
GO:0033233 |
4 |
0.013
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.013
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.013
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.013
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.013
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.013
|
|
|
limb development
|
GO:0060173 |
166 |
0.013
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.013
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.013
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.013
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.013
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.013
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.012
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.012
|
|
|
artery development
|
GO:0060840 |
53 |
0.012
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.012
|
|
|
demethylation
|
GO:0070988 |
23 |
0.012
|
|
|
histone deubiquitination
|
GO:0016578 |
2 |
0.012
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.012
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.012
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.012
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.012
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.012
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.012
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.012
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.012
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.012
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.012
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.012
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
12 |
0.012
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.012
|
|
|
regulation of t cell anergy
|
GO:0002667 |
4 |
0.012
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.012
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.012
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.012
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.012
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.012
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.012
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.011
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.011
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.011
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.011
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.011
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.011
|
|
|
t cell anergy
|
GO:0002870 |
4 |
0.011
|
|
|
mirna catabolic process
|
GO:0010587 |
2 |
0.011
|
|
|
lung development
|
GO:0030324 |
164 |
0.011
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.011
|
|
|
catecholamine secretion
|
GO:0050432 |
15 |
0.011
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.011
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.011
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.011
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.011
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.011
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.011
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.011
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.011
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.011
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.011
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.011
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.011
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.011
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.011
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.011
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.011
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.011
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.011
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.011
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.011
|
|
|
lymphocyte anergy
|
GO:0002249 |
4 |
0.011
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.011
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.011
|
|
|
histone h4 k20 methylation
|
GO:0034770 |
8 |
0.011
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.011
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.011
|
|
|
nuclear transcribed mrna poly a tail shortening
|
GO:0000289 |
7 |
0.011
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.010
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.010
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.010
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.010
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.010
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.010
|
|
|
somatic diversification of immunoglobulins
|
GO:0016445 |
43 |
0.010
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.010
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.010
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.010
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.010
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.010
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.010
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.010
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.010
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.010
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.010
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.010
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.010
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.010
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.010
|
|
|
negative regulation of histone modification
|
GO:0031057 |
18 |
0.010
|
|